nach oben

Erschienen in:

01.01.2010 | Drug Reactions and Interactions

First reports of serious adverse drug reactions in recent weeks

Erschienen in: Drugs & Therapy Perspectives | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

The following table contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage. Reactions and the customized Reactions Pharmacovigilance Service are produced by Adis, a Wolters Kluwer Business, and monitor >4000 journals, including relevant MEDLINE- and EMBASE-indexed journals, as well as companion journal supplements, major scientific meetings, the newsletters from the >80 national centres participating in the WHO International Drug Monitoring Programme, media releases, pharmaceutical company websites, and regulatory agency websites. …

Triaridis S, Tsiropoulos G, Rachovitsas D, et al. Spontaneous haematoma of the pharynx due to a rare drug interaction. Hippokratia 2009; 13(3): 175–7PubMed

Jalocha L, Wojtun S, Wojtkowiak M, et al. Oligosymptomatic alimentary tract perforation in course of Crohn’s disease in patient treated with anti-TNF alfa antibodies [in Polish]. Pol Merkuriusz Lek 2009 May; 26(155): 491–2

Stevens RB, Yannam GR, Skorupa JY, et al. Acute transverse myelitis and paralysis in a kidney-pancreas recipient. Transpl Int 2009 Jul; 22(7): 766–8PubMedCrossRef

Fuhrer GS, Parrish S, Turner JF, et al. Supplement-induced lung disease: report of a case of organizing pneumonia secondary to biacalcin and catechin [abstract]. 75th Annual Meeting of the American College of Chest Physicians; 2009 Oct 31–Nov 5; San Diego (CA)

Leclair M-A, Maynard B, St-Pierre C. Acute generalized exanthematous pustulosis with severe organ dysfunction. CMAJ 2009 Sep 15; 181(6–7): 393–6PubMed

Pantano F, Silletta M, Iovieno A, et al. Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab. Int J Colorectal Dis 2009; 24(10): 1247–8PubMedCrossRef

Crosland L, Longcroft-Wheaton G, Fraser J, et al. Antidepressants, thiazide diuretics and alcoholism: central pontine myelinolysis waiting to happen? Br J Hosp Med 2009 May; 70(5): 296–7

Chen S-C, Huang M-C, Fan C-C. Potentially fatal interaction between colchicine and disulfiram. Prog Neuropsychopharmacol Biol Psychiatry 2009 Oct 1; 33(7): 1281PubMedCrossRef

Reuss R, Reuter I, Jauss M, et al. Torticollis under cyclobenzaprine. Pharmacology 2009 Aug; 84(2): 91–2PubMedCrossRef

Ganguli A, Walker L, Fitzgerald RJ, et al. Spontaneous hemothorax following anticoagulation with low-molecular-weight heparin. Ann Pharmacother 2009 Sep; 43(9): 1528–31PubMedCrossRef

Mehdizadeh M, Nowroozzadeh MH. Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption. Clin Exp Optom 2009 Jul; 92(4): 392–4PubMedCrossRef

de Groot JWB, Gosselink AT, Ottervanger JP. Acute ST-segment elevation myocardial infarction associated with diclofenac-induced anaphylaxis: case report. Am J Crit Care 2009 Jul; 18(4): 386–8

Rowley M, Riutort K, Shapiro D, et al. Methylene blue-associated serotonin syndrome: a green encephalopathy after parathyroidectomy. Neurocrit Care 2009; 11(1): 88–93PubMedCrossRef

Huang K-Y, Yang R-S, Hsieh C-C. Simultaneous osteonecrosis and osteomyelitis in a patient with cancer of the breast. J Bone Joint Surg Br 2009 Sep; 91(9): 1249–51PubMedCrossRef

Lin J, Anania F. Recombinant factor VIIa in cirrhosis [abstract no. P1026]. 74th Annual Scientific Meeting of the American College of Gastroenterology; 2009 Oct 23–28; San Diego (CA)

Grau AM, Bollu M, George M, et al. Pneumatosis intestinalis in a patient with lung cancer being treated with erlotinib [abstract no. P571]. 74th Annual Scientific Meeting of the American College of Gastroenterology; 2009 Oct 23–28; San Diego (CA)

Dominguez-Lenero V, Barrera-Ledesma M, Romero-Alonso M, et al. Stevens-Johnson sydnrome and toxic hepatitis due to esomeprazole [in Spanish]. Farm Hosp 2009 Apr; 33(2): 118–9PubMedCrossRef

Garg A, Mohammed M. Decreased INR response secondary to warfarin-flucloxacillin interaction. Ann Pharmacother 2009 Jul–Aug; 43(7): 1374–5PubMedCrossRef

Pasa S, Altintas A, Cil T, et al. Fetal loss in a patient with acute myeloblastic leukemia associated with FLAG-IDA regime. UHOD 2009; 19(2): 110–2

Lu BR, Fenton LZ, O’Connor J, et al. Epstein-Barr virus-related optic neuritis as a precursor to the development of posttransplant lymphoproliferative disease. J Pediatr Gastroenterol Nutr 2009 Aug; 49(2): 243–5PubMedCrossRef

Colak A, Ege T, Arar C, et al. A severe complication of accidental epidural administration of glutaraldehyde. Trakya Uni Tip Fakultesi Der 2009; 26(1): 83–6

Ide N, Gotou S, Mori M. Hospital pharmacists prevented advance of lithium intoxication through pharmaceutical interventions [in Japanese]. Yakugaku Zasshi 2009 Aug; 129(8): 1007–11PubMedCrossRef

Osband AJ, Laskow DA, Mann RA, et al. Sweet syndrome after kidney transplantation. Transplant Proc 2009 Jun; 41(5): 1954–6PubMedCrossRef

Chang J, Kane S. Case of ulcerative colitis treated with infliximab complicated by hepatic hemangioendothelioma [abstract no. P737]. 74th Annual Scientific Meeting of the American College of Gastroenterology; 2009 Oct 23–28; San Diego (CA)

Samson M, Audia S, Duchêne C, et al. Crohn’s disease during the course of multiple sclerosis: role of interferon-beta therapy [in French]. Rev Med Interne 2009 Sep; 30(9): 816–9PubMedCrossRef

Cserti-Gazdewich CM, Pendergrast JM, Reis M. Postvaccination hyperhemolysis coinciding with remission of Epstein Barr virus (EBV)-associated immune thrombocytopenic purpura (ITP). Am J Hematol 2009 Sep; 84(9): 612–3PubMedCrossRef

Loo YK. Nicotine-induced osteonecrosis: a case report. Dent Update 2009 Jun; 36(5): 289–91PubMed

Thomason AR, Waldrop BA, Price SO. Nortriptyline cardiac toxicity resulting from a probable interaction with telithromycin. Hosp Pharm 2009 May; 44(5): 397–400CrossRef

Nagao Y, Hiromatsu Y, Nakashima T, et al. Graves’ ophthalmopathy and tongue cancer complicated by peg-interferon α-2b and ribavirin therapy for chronic hepatitis C: a case report and review of the literature. Mol Med Rep 2008 Sep–Oct; 1(5): 625–31

Lillo N, Costable J, Storch I. Rifaximin: a predisposing agent to Clostridium difficile? [abstract no. P1074]. 74th Annual Scientific Meeting of the American College of Gastroenterology; 2009 Oct 23–28; San Diego (CA)

Choudhary AS, Robinson GM. Can β agonists cause dilated cardiomyopathy? Heart Lung Circ 2009 Oct; 18(5): 367–9PubMedCrossRef

Rangel GA, Ariceta G. Growth failure associated with sirolimus: case report. Pediatr Nephrol 2009; 24(10): 2047–50PubMedCrossRef

Binello E, Germano IM. Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology? J Neuro Oncol 2009 Aug; 94(1): 145–8CrossRef

Aregawi D, Lopez D, Wick M, et al. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neuro Oncol 2009; 94(3): 439–43CrossRef

Clajus C, Spiegel J, Brocker V, et al. Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination. BMC Nephrol 2009 Aug 5; 10(21): e1–5

Ramirez C, Hernandez AF, Mendez V, et al. Case report of mucormycosis in a patient with secondary methimazole-induced agranulocytosis [in Spanish]. Gaceta Med Mex 2009 May–Jun; 145(3): 235–8

Duparc A, Gosset P, Caron J, et al. Acute generalized exanthematous pustulosis caused by varenicline. J Eur Acad Dermatol Venereol 2009 Sep; 23(9): 1111–2PubMedCrossRef

Franck AJ, Sliter LR. Acute hepatic injury associated with varenicline in a patient with underlying liver disease. Ann Pharmacother 2009 Sep; 43(9): 1539–43PubMedCrossRef

Hirota Y, Ogawa W, Murawaki A, et al. Deterioration of glycaemic control associated with anti-insulin antibodies likely induced by health supplements. Diabet Med 2009 Sep; 26(9): 948–51PubMedCrossRef

Koga M, Kodaka F, Miyata H, et al. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine. Acta Psychiatr Scand 2009 Oct; 120(4): 329–33PubMedCrossRef

Wang TS, Saggar R. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients [abstract]. 75th Annual Meeting of the American College of Chest Physicians; 2009 Oct 31–Nov 5; San Diego (CA)

Raziorrouh B, Samtleben W, Wessely M, et al. Nephrotic syndrome after 210 mCi 90Y-Dotatoc therapy of a metastatic neuroendocrine tumor [in German]. Nieren Hochdruckkr 2009 Aug; 38(8): 399–402

Kim S-W, Shin I-S, Kim J-M, et al. The 5-HT₂ receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. Clin Neuropharmacol 2009 Jul–Aug; 32(4): 224–6PubMedCrossRef

Titel: First reports of serious adverse drug reactions in recent weeks
Publikationsdatum: 01.01.2010
Verlag: Springer International Publishing
Erschienen in: Drugs & Therapy Perspectives / Ausgabe 1/2010
Print ISSN: 1172-0360
Elektronische ISSN: 1179-1977
DOI: https://doi.org/10.2165/11204080-000000000-00000

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

First reports of serious adverse drug reactions in recent weeks

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

News from the 38th European Symposium on Clinical Pharmacy; 3–6 November 2009; Geneva

Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

Worldwide control of trachoma involves a strategy combining surgery, antibacterials, facial cleanliness and environmental improvements

Fesoterodine: a guide to its use in overactive bladder syndrome

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder